Blocking antibodies against human integrin beta1, recombinant human interleukin-1 beta, and recombinant human BMP2 were obtained from R&D systems. Purified COL2A1 was purchased from Chondrex, Inc. (Redmond, WA, USA). U0126 and SP600125 were from CST. SB505124 was obtained from MedChemExpress (Monmouth Junction, NJ, USA).
Sb 505124
SB-505124 is a small molecule compound that functions as a selective inhibitor for the transforming growth factor-beta (TGF-β) type I receptor. It exhibits a high level of potency and selectivity in inhibiting the TGF-β signaling pathway. The core function of SB-505124 is to modulate the TGF-β signaling cascade.
Lab products found in correlation
4 protocols using sb 505124
Antibody Validation Protocols for Cellular Signaling
Blocking antibodies against human integrin beta1, recombinant human interleukin-1 beta, and recombinant human BMP2 were obtained from R&D systems. Purified COL2A1 was purchased from Chondrex, Inc. (Redmond, WA, USA). U0126 and SP600125 were from CST. SB505124 was obtained from MedChemExpress (Monmouth Junction, NJ, USA).
Transfection Protocols for miRNA and siRNA
Cell Line Cultivation and Inhibitor Treatments
Microglia Activation and Modulation Protocols
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!